Meneghini, Bianca C; Tavares, Elaine R; Guido, Maria C; Tavoni, Thauany M; Stefani, Hélio Alexandre 
; Kalil-filho, Roberto; Maranhão, Raul Cavalcante
Source: Vascular pharmacology. Unidades: FM, FCF
Subjects: NANOPARTÍCULAS, LIPÍDEOS, ANTINEOPLÁSICOS, ARTERIOSCLEROSE, INFLAMAÇÃO, COELHOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MENEGHINI, Bianca C et al. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascular pharmacology, v. 115, p. 46-54, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.vph.2019.02.003. Acesso em: 18 nov. 2024.APA
Meneghini, B. C., Tavares, E. R., Guido, M. C., Tavoni, T. M., Stefani, H. A., Kalil-filho, R., & Maranhão, R. C. (2019). Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model. Vascular pharmacology, 115, 46-54. doi:10.1016/j.vph.2019.02.003NLM
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Stefani HA, Kalil-filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Vascular pharmacology. 2019 ; 115 46-54.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.vph.2019.02.003Vancouver
Meneghini BC, Tavares ER, Guido MC, Tavoni TM, Stefani HA, Kalil-filho R, Maranhão RC. Lipid core nanoparticles as vehicle for docetaxel reduces atherosclerotic lesion, inflammation, cell death and proliferation in an atherosclerosis rabbit model [Internet]. Vascular pharmacology. 2019 ; 115 46-54.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.vph.2019.02.003
